Advertisement

Sports Medicine

, Volume 39, Issue 5, pp 339–344 | Cite as

Genetic Testing and Sports Medicine Ethics

  • Michael John McNameeEmail author
  • Arno Müller
  • Ivo van Hilvoorde
  • Søren Holm
Current Opinion

Abstract

Sports medicine ethics is neither a well established branch of sports medicine nor of medical ethics. It is therefore important to raise to more general awareness some of the significant ethical implications of sports medicine practices. The field of genetics in sports is likewise in its infancy and raises significant ethical concerns. It is not yet clear how genetics will alter our understanding of human potential and performance in sports. While a number of professional medical bodies accept genetic interventions of a therapeutic nature, we argue that the use of genetic technologies to predict sports potential may well breach both the European bioethics convention and North American anti-discrimination legislation, which are designed to support important ethical ideals and the ongoing commitment of the physician to the welfare of their patient. We highlight further ethical problems associated with confidentiality and consent that may arise in genetic testing as opposed to more conventional methods of testing in sports medicine. We conclude that genetic testing in sport that is not strictly limited to the protection of the athlete against harm, should be viewed in a very sceptical light by sports medicine professionals.

Keywords

Genetic Testing Hypertrophic Cardiomyopathy National Football League Professional Sport Predictive Genetic Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

Dr Arno Müller’s research project ‘Sports, Ethics and Genomics’ at Maastricht University, Maastricht, the Netherlands, Department Health, Ethics and Society is funded by the Centre for Society and Genomics (CSG). The CSG is a centre of excellence of the Netherlands Genomics Initiative (NGI).

References

  1. 1.
    Genetic Technologies. Sports Performance ACTN3 Sports Gene Test® 2006 [online]. Available from URL: http://www.gtg.com.au [Accessed 2009 Feb 27]
  2. 2.
    The Human Genetics Society of Australasia. HGSA position statement on genetic testing and sport performance. Alexandria: The Human Genetics Society of Australasia, 2007Google Scholar
  3. 3.
    Williams AG, Wackerhage H, Miah A, et al. Genetic research and testing in sport and exercise science: British Association of Sport and Exercise Sciences position stand [online]. Available from URL: http://www.bases.org.uk/newsite/pdf/BASES [Accessed 2007 Sep 15]Google Scholar
  4. 4.
    Savulescu J, Foddy B. Comment: genetic test available for sports performance. Br J Sports Med 2005 Aug 1; 39 (8): 472PubMedCrossRefGoogle Scholar
  5. 5.
    Miah A, Rich E. Genetic tests for ability? Talent identification and the value of an open future. Sport Educ Soc 2006; 11 (3): 259–73CrossRefGoogle Scholar
  6. 6.
    Munthe C. Selected champions: making winners in the age of genetic technology. In: Tamburrini CT, Tännsjö T, editor. Values in sport: elitism, nationalism, gender equality and the scientific manufacture of winners. London: Taylor and Francis, 2000: 217–31Google Scholar
  7. 7.
    Munthe C. Ethical aspects of controlling genetic doping. In: Tamburrini C, Tännsjö T, editors. The genetic technology and sport: ethical questions. London: Routledge, 2005: XII, 223 SGoogle Scholar
  8. 8.
    Murray TH. Assessing genetic technologies: two ethical issues. Int J Technol Assess Health Care 1994 Fall; 10 (4): 573–82PubMedCrossRefGoogle Scholar
  9. 9.
    Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete’s heart: a clinical problem of increasing magnitude and significance. Heart 2005 Nov; 91 (11): 1380–2PubMedCrossRefGoogle Scholar
  10. 10.
    Corrado D, Thiene G. Protagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. Heart Rhythm 2007; 4 (4): 520–4PubMedCrossRefGoogle Scholar
  11. 11.
    Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26 (14): 1422–45PubMedCrossRefGoogle Scholar
  12. 12.
    Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002 Mar 13; 287 (10): 1308–20PubMedCrossRefGoogle Scholar
  13. 13.
    Maron BJ. Sudden death in young athletes. N Engl J Med 2003 Sep 11; 349 (11): 1064–75PubMedCrossRefGoogle Scholar
  14. 14.
    Council of Europe. Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Oviedo: The Council of Europe, 1997Google Scholar
  15. 15.
    H.R.493–110th Congress, 2008. Genetic Information Non-discrimination Act of 2008: an act to prohibit discrimination on the basis of genetic information with respect to health insurance and employment [online]. Available from URL: http://www.govtrack.us/congress/billtext.xpd?bill=h110 [Accessed 2008 Oct 3]
  16. 16.
    Johnson R. The unique ethics of sports medicine. Clin Sports Med 2004; 23 (2): 175–82PubMedCrossRefGoogle Scholar
  17. 17.
    Dunn WR, George MS, Churchill L, et al. Ethics in sports medicine. Am J Sports Med 2007 May 1; 35 (5): 840–4PubMedCrossRefGoogle Scholar
  18. 18.
    Waddington I, Malcolm D, Roderick M, et al. Drug use in English professional football. Br J Sports Med 2005 April 1; 39 (4): e18CrossRefGoogle Scholar
  19. 19.
    Rankinen T, Bray MS, Hagberg JM, et al. The human gene map for performance and health-related fitness phenotypes: the 2005 update. Med Sci Sports Exerc 2006 Nov; 38 (11): 1863–88PubMedCrossRefGoogle Scholar
  20. 20.
    Unal M, Ozer Unal D. Gene doping in sports. Sports Med 2004; 34 (6): 357–62PubMedCrossRefGoogle Scholar
  21. 21.
    Miah A. Genetically modified athletes: biomedical ethics, gene doping and sport. London: Routledge, 2004Google Scholar
  22. 22.
    Clayton EW. Ethical, legal, and social implications of genomic medicine. N Engl J Med 2003 Aug 7; 349 (6): 562–9PubMedCrossRefGoogle Scholar
  23. 23.
    Yang N, MacArthur DG, Gulbin JP, et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 2003 Sep; 73 (3): 627–31PubMedCrossRefGoogle Scholar
  24. 24.
    Lucia A, Olivan J, Gomez-Gallego F, et al. Citius and longius (faster and longer) with no alpha-actinin-3 in skeletal muscles? Br J Sports Med 2007 Sep; 41 (9): 616–7PubMedCrossRefGoogle Scholar
  25. 25.
    Roth SM. ACTN3 was never ‘the’ gene for speed. Br J Sports Med 2007 Sep 24 (electronic letter) [online]. Available from URL: http://bjsm.bmj.com/cgi/eletters/41/9/616#1707 [Accessed 2008 Dec 11]Google Scholar
  26. 26.
    Janssens ACJW, Gwinn M, Bradley LA, et al. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008; 82 (3): 593–9PubMedCrossRefGoogle Scholar
  27. 27.
    Pigozzi F, Rizzo M. Sudden death in competitive athletes. Clin Sports Med 2008; 27 (1): 153–81PubMedCrossRefGoogle Scholar
  28. 28.
    Trusty JM, Beinborn DS, Jahangir A. Dysrhythmias and the athlete. AACN Clin Issues 2004 Jul-Sep; 15 (3): 432–48PubMedCrossRefGoogle Scholar
  29. 29.
    Garratt CJ. Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement. Heart 2008 Apr 1; 94 (4): 502–7Google Scholar
  30. 30.
    Jordan BD, Relkin NR, Ravdin LD, et al. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury inboxing. JAMA 1997 Jul 9; 278 (2): 136–40PubMedCrossRefGoogle Scholar
  31. 31.
    McCrory P. Boxing and the risk of chronic brain injury. BMJ 2007 Oct 20; 335 (7624): 781–2PubMedCrossRefGoogle Scholar
  32. 32.
    Shickle D, Chadwick R. The ethics of screening: is ‘screeningitis’ an incurable disease? J Med Ethics 1994 Mar 1; 20 (1): 12–8PubMedCrossRefGoogle Scholar
  33. 33.
    Gillon R. Ethics needs principles–four can encompass the rest–and respect for autonomy should be ‘first amongequals’. J Med Ethics 2003 Oct 1; 29 (5): 307–12PubMedCrossRefGoogle Scholar
  34. 34.
    Murray T. Genetic exceptonalism and future diaries: is genetic information different from other medical information? In: Rothstein MA, editor. Genetic secrets: protecting privacy and confidentiality in the genetic era. New Haven(CT): Yale University Press, 1997: xvi, 511Google Scholar
  35. 35.
    Yesley MS. Genetic privacy, discrimination, and social policy: challenges and dilemmas. Microb Comp Genomics 1997; 2 (1): 19–35PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2009

Authors and Affiliations

  • Michael John McNamee
    • 1
    Email author
  • Arno Müller
    • 2
  • Ivo van Hilvoorde
    • 3
  • Søren Holm
    • 4
  1. 1.Department of Philosophy, History and Law, School of Health ScienceSwansea UniversitySwanseaUK
  2. 2.Department of Health, Ethics and SocietyMaastricht UniversityMaastrichtthe Netherlands
  3. 3.Research Institute MOVE, Faculty of Human Movement SciencesVU University AmsterdamAmsterdamthe Netherlands
  4. 4.Cardiff Law SchoolCardiff University Law Building, Museum AvenueCardiffUK

Personalised recommendations